{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T16:15:11Z","timestamp":1788365711476,"version":"build-2803163510"},"reference-count":173,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Long noncoding RNAs (lncRNAs) constitute a distinctive subset of RNA molecules with limited protein-coding potential, which exert crucial impacts on various biological activities. In the context of cancer, dysregulated lncRNAs function as essential regulators that affect tumor initiation and malignant progression. These lncRNAs serve as competitive endogenous RNAs (ceRNAs) through sponging microRNAs and regulating the expression of targeted genes. Moreover, they also directly bind to RNA-binding proteins, which can be integrated into a complex mechanistic network. E2F1, an extensively studied transcription factor, mediates multiple malignant behaviors by regulating cell cycle progression, tumor metastasis, and therapeutic response. Emerging evidence suggests that lncRNAs play a pivotal role in regulating the E2F1 pathway. This review aims to elucidate the intricate gene regulatory programs between lncRNAs and E2F1 in cancer progression. We elaborate on distinct mechanistic networks involved in cancer progression, emphasizing the potential of the lncRNAs\/E2F1 axes as promising targets for cancer therapy. Additionally, we provide novel perspectives on current evidence, limitations, and future directions for targeting lncRNAs in human cancers. Fully deciphering the intricate network of lncRNA\/E2F1-mediated regulatory mechanisms in cancer could facilitate the translation of current findings into clinical course, such efforts ultimately significantly improve the clinical prognosis of cancer patients.<\/jats:p>","DOI":"10.3389\/fphar.2024.1432490","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T05:05:04Z","timestamp":1721883904000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Current concepts of the crosstalk between lncRNA and E2F1: shedding light on the cancer therapy"],"prefix":"10.3389","volume":"15","author":[{"given":"Peng","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.semcancer.2023.01.002","article-title":"Nanomedicine as potential cancer therapy via targeting dysregulated transcription factors","volume":"89","author":"Ahmad","year":"2023","journal-title":"Semin. Cancer Biol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1016\/j.jcf.2022.12.016","article-title":"Gene, RNA, and ASO-based therapeutic approaches in cystic fibrosis","volume":"22","author":"Allaire","year":"2023","journal-title":"J. Cyst. Fibros."},{"key":"B3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12575-022-00171-1","article-title":"CRISPR\/Cas9-mediated LINC00511 knockout strategies, increased apoptosis of breast cancer cells via suppressing antiapoptotic genes","volume":"24","author":"Azadbakht","year":"2022","journal-title":"Biol. Proced. Online"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41467-023-36826-0","article-title":"Long non-coding RNA-derived peptides are immunogenic and drive a potent anti-tumour response","volume":"14","author":"Barczak","year":"2023","journal-title":"Nat. Commun."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/j.ymthe.2023.01.005","article-title":"RNA editing: expanding the potential of RNA therapeutics","volume":"31","author":"Booth","year":"2023","journal-title":"Mol. Ther."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e202009045","DOI":"10.1083\/jcb.202009045","article-title":"LNCcation: lncRNA localization and function","volume":"220","author":"Bridges","year":"2021","journal-title":"J. Cell Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41568-019-0196-7","article-title":"Targeting transcription factors in cancer - from undruggable to reality","volume":"19","author":"Bushweller","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"B8","doi-asserted-by":"publisher","first-page":"216590","DOI":"10.1016\/j.canlet.2023.216590","article-title":"Natural compounds modulating mitophagy: implications for cancer therapy","volume":"582","author":"Cao","year":"2024","journal-title":"Cancer Lett."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.7150\/thno.71144","article-title":"CRISPR-Cas9 library screening approach for anti-cancer drug discovery: overview and perspectives","volume":"12","author":"Chan","year":"2022","journal-title":"Theranostics"},{"key":"B10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12943-024-01988-y","article-title":"Loss of lncRNA LINC01056 leads to sorafenib resistance in HCC","volume":"23","author":"Chan","year":"2024","journal-title":"Mol. Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"4751","DOI":"10.1111\/jcmm.13726","article-title":"Long non-coding RNA NNT-AS1 sponges miR-424\/E2F1 to promote the tumorigenesis and cell cycle progression of gastric cancer","volume":"22","author":"Chen","year":"2018","journal-title":"J. Cell Mol. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1038\/s41388-021-01671-2","article-title":"LncRNA SNHG6 promotes G1\/S-phase transition in hepatocellular carcinoma by impairing miR-204-5p-mediated inhibition of E2F1","volume":"40","author":"Chen","year":"2021","journal-title":"Oncogene"},{"key":"B13","doi-asserted-by":"publisher","first-page":"17902","DOI":"10.18632\/aging.103332","article-title":"Long noncoding RNA SBF2-AS1 contributes to the growth and metastatic phenotypes of NSCLC via regulating miR-338-3p\/ADAM17 axis","volume":"12","author":"Chen","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.omtn.2019.04.004","article-title":"Long noncoding RNA SBF2-AS1 is critical for tumorigenesis of early-stage lung adenocarcinoma","volume":"16","author":"Chen","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"B15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s12195-021-00714-8","article-title":"LINC00852 regulates cell proliferation, invasion, migration and apoptosis in hepatocellular carcinoma via the miR-625\/E2F1 Axis","volume":"15","author":"Chen","year":"2022","journal-title":"Cell Mol. Bioeng."},{"key":"B16","doi-asserted-by":"publisher","first-page":"188336","DOI":"10.1016\/j.bbcan.2019.188336","article-title":"The conflicting role of E2F1 in prostate cancer: a matter of cell context or interpretational flexibility?","volume":"1873","author":"Chun","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"B17","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3389\/fendo.2017.00311","article-title":"E2F1, a novel regulator of metabolism","volume":"8","author":"Denechaud","year":"2017","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e2511","DOI":"10.21769\/BioProtoc.2511","article-title":"Antisense oligonucleotide-mediated knockdown in mammary tumor organoids","volume":"7","author":"Diermeier","year":"2017","journal-title":"Bio Protoc."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.21037\/jgo-22-674","article-title":"Bioinformatic-based mechanism identification of E2F1-related ceRNA and E2F1 immunoassays in hepatocellular carcinoma","volume":"13","author":"Dong","year":"2022","journal-title":"J. Gastrointest. Oncol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12964-024-01607-9","article-title":"Potentials and future perspectives of multi-target drugs in cancer treatment: the next generation anti-cancer agents","volume":"22","author":"Doostmohammadi","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"B21","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nbt.3802","article-title":"Overcoming cellular barriers for RNA therapeutics","volume":"35","author":"Dowdy","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.omtn.2022.05.024","article-title":"RNA modifications can affect RNase H1-mediated PS-ASO activity","volume":"28","author":"Doxtader Lacy","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/cas.16181","article-title":"SNHG15-mediated feedback loop interplays with HNRNPA1\/SLC7A11\/GPX4 pathway to promote gastric cancer progression","author":"Duan","year":"2024","journal-title":"Cancer Sci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"113609","DOI":"10.1016\/j.biopha.2022.113609","article-title":"LncRNA-miRNA axis in tumor progression and therapy response: an emphasis on molecular interactions and therapeutic interventions","volume":"154","author":"Entezari","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"B25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cytogfr.2016.02.001","article-title":"E2F1 transcription factor and its impact on growth factor and cytokine signaling","volume":"31","author":"Ertosun","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"key":"B26","first-page":"757","article-title":"A comprehensive review of the roles of E2F1 in colon cancer","volume":"10","author":"Fang","year":"","journal-title":"Am. J. Cancer Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.1158\/0008-5472.Can-20-1031","article-title":"ERINA is an estrogen-responsive LncRNA that drives breast cancer through the E2F1\/RB1 pathway","volume":"80","author":"Fang","year":"","journal-title":"Cancer Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"16205","DOI":"10.18632\/oncotarget.7578","article-title":"miR-124 downregulation leads to breast cancer progression via LncRNA-MALAT1 regulation and CDK4\/E2F1 signal activation","volume":"7","author":"Feng","year":"2016","journal-title":"Oncotarget"},{"key":"B29","doi-asserted-by":"publisher","first-page":"599332","DOI":"10.3389\/fmolb.2020.599332","article-title":"E2F1: cause and consequence of DNA replication stress","volume":"7","author":"Fouad","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.celrep.2013.12.013","article-title":"RNAi factors are present and active in human cell nuclei","volume":"6","author":"Gagnon","year":"2014","journal-title":"Cell Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/s41573-024-00920-9","article-title":"Targeting immunogenic cell stress and death for cancer therapy","volume":"23","author":"Galluzzi","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"B32","doi-asserted-by":"publisher","first-page":"226","DOI":"10.5603\/FHC.a2021.0023","article-title":"Actinidia chinensis Planch. root extract inhibits the proliferation, migration and invasion of breast cancer cells via the AKT\/GSK-3\u03b2 signaling pathway","volume":"59","author":"Gan","year":"2021","journal-title":"Folia Histochem Cytobiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cld.2022.08.004","article-title":"Hepatocellular carcinoma: new developments","volume":"27","author":"Ganesan","year":"2023","journal-title":"Clin. Liver Dis."},{"key":"B34","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12964-023-01043-1","article-title":"c-MYC mediates the crosstalk between breast cancer cells and tumor microenvironment","volume":"21","author":"Gao","year":"2023","journal-title":"Cell Commun. Signal"},{"key":"B35","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2147\/ott.S116178","article-title":"Long noncoding RNA CRNDE functions as a competing endogenous RNA to promote metastasis and oxaliplatin resistance by sponging miR-136 in colorectal cancer","volume":"10","author":"Gao","year":"2017","journal-title":"Onco Targets Ther."},{"key":"B36","doi-asserted-by":"publisher","first-page":"14979","DOI":"10.1007\/s13277-016-5389-z","article-title":"Expression and prognostic value of E2F activators in NSCLC and subtypes: a research based on bioinformatics analysis","volume":"37","author":"Gao","year":"2016","journal-title":"Tumour Biol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa2107454","article-title":"CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis","volume":"385","author":"Gillmore","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41523-019-0144-4","article-title":"LncRNA RP11-19E11 is an E2F1 target required for proliferation and survival of basal breast cancer","volume":"6","author":"Giro-Perafita","year":"2020","journal-title":"NPJ Breast Cancer"},{"key":"B39","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/s41419-023-06277-y","article-title":"The long non-coding RNA TAZ-AS202 promotes lung cancer progression via regulation of the E2F1 transcription factor and activation of Ephrin signaling","volume":"14","author":"Gobbi","year":"2023","journal-title":"Cell Death Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12964-024-01577-y","article-title":"CDK7 in breast cancer: mechanisms of action and therapeutic potential","volume":"22","author":"Gong","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"B41","doi-asserted-by":"publisher","first-page":"18312","DOI":"10.1038\/s41598-022-21492-x","article-title":"Network analysis reveals that the tumor suppressor lncRNA GAS5 acts as a double-edged sword in response to DNA damage in gastric cancer","volume":"12","author":"Gupta","year":"2022","journal-title":"Sci. Rep."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1007\/s12282-022-01383-9","article-title":"Neurospora crassa is a potential source of anti-cancer agents against breast cancer","volume":"29","author":"Han","year":"2022","journal-title":"Breast Cancer"},{"key":"B43","doi-asserted-by":"publisher","first-page":"106418","DOI":"10.1016\/j.phrs.2022.106418","article-title":"Long non-coding RNA (lncRNA) H19 in human cancer: from proliferation and metastasis to therapy","volume":"184","author":"Hashemi","year":"2022","journal-title":"Pharmacol. Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41416-021-01564-x","article-title":"ESR1 mutations and therapeutic resistance in metastatic breast cancer: progress and remaining challenges","volume":"126","author":"Herzog","year":"2022","journal-title":"Br. J. Cancer"},{"key":"B45","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1080\/21655979.2022.2025697","article-title":"N6-methyladenosine-induced SVIL antisense RNA 1 restrains lung adenocarcinoma cell proliferation by destabilizing E2F1","volume":"13","author":"Hu","year":"2022","journal-title":"Bioengineered"},{"key":"B46","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12943-019-1122-z","article-title":"Hypoxia induced LUCAT1\/PTBP1 axis modulates cancer cell viability and chemotherapy response","volume":"19","author":"Huan","year":"2020","journal-title":"Mol. Cancer"},{"key":"B47","doi-asserted-by":"publisher","first-page":"noae036","DOI":"10.1093\/neuonc\/noae036","article-title":"LncRNA LUCAT1 promotes glioblastoma progression by enhancing HIF1\u03b1 activity","author":"Huang","year":"","journal-title":"Neuro Oncol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"122576","DOI":"10.1016\/j.lfs.2024.122576","article-title":"The tale of SOX2: focusing on lncRNA regulation in cancer progression and therapy","volume":"344","author":"Huang","year":"","journal-title":"Life Sci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bbagrm.2015.07.014","article-title":"Bioinformatics tools for lncRNA research","volume":"1859","author":"Iwakiri","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"B50","doi-asserted-by":"publisher","first-page":"216831","DOI":"10.1016\/j.canlet.2024.216831","article-title":"Colorectal cancer initiation: understanding early-stage disease for intervention","volume":"589","author":"Jiang","year":"2024","journal-title":"Cancer Lett."},{"key":"B51","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s13046-022-02412-3","article-title":"NCAPD3 enhances Warburg effect through c-myc and E2F1 and promotes the occurrence and progression of colorectal cancer","volume":"41","author":"Jing","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"122637","DOI":"10.1016\/j.lfs.2024.122637","article-title":"The function of the ELF3 gene and its mechanism in cancers","volume":"346","author":"Ju","year":"2024","journal-title":"Life Sci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.semcancer.2022.10.001","article-title":"Deregulated transcription factors in cancer cell metabolisms and reprogramming","volume":"86","author":"Kant","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.semcancer.2023.03.004","article-title":"Role of E2F transcription factor in oral cancer: recent insight and advancements","volume":"92","author":"Kassab","year":"2023","journal-title":"Semin. Cancer Biol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41568-019-0143-7","article-title":"The broken cycle: E2F dysfunction in cancer","volume":"19","author":"Kent","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"B57","doi-asserted-by":"publisher","first-page":"104351","DOI":"10.1016\/j.critrevonc.2024.104351","article-title":"Recent strategies to overcome breast cancer resistance","volume":"197","author":"Khan","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"189003","DOI":"10.1016\/j.bbcan.2023.189003","article-title":"Snail transcription factors as key regulators of chemoresistance, stemness and metastasis of ovarian cancer cells","volume":"1878","author":"Kielbik","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"B59","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/s41571-023-00811-9","article-title":"Targeting cancer with mRNA-lipid nanoparticles: key considerations and future prospects","volume":"20","author":"Kon","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"111917","DOI":"10.1016\/j.biopha.2021.111917","article-title":"CRISPR: history and perspectives to the future","volume":"141","author":"Kozovska","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"B61","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12935-023-03034-1","article-title":"MALAT1\/mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1\/AMPK signaling pathway","volume":"23","author":"Li","year":"","journal-title":"Cancer Cell Int."},{"key":"B62","doi-asserted-by":"publisher","first-page":"663558","DOI":"10.3389\/fmed.2021.663558","article-title":"Long non-coding RNA LINC00847 induced by E2F1 accelerates non-small cell lung cancer progression through targeting miR-147a\/IFITM1 Axis","volume":"8","author":"Li","year":"","journal-title":"Front. Med. (Lausanne)"},{"key":"B63","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13148-023-01428-6","article-title":"E2F1 combined with LINC01004 super-enhancer to promote hepatocellular carcinoma cell proliferation and metastasis","volume":"15","author":"Li","year":"","journal-title":"Clin. Epigenetics"},{"key":"B64","doi-asserted-by":"publisher","first-page":"2003094","DOI":"10.1002\/advs.202003094","article-title":"LncRNA lnc-APUE is repressed by HNF4\u03b1 and promotes G1\/S phase transition and tumor growth by regulating MiR-20b\/E2F1 Axis","volume":"8","author":"Li","year":"","journal-title":"Adv. Sci. (Weinh)"},{"key":"B65","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.semcancer.2022.08.001","article-title":"Deregulated transcription factors and poor clinical outcomes in cancer patients","volume":"86","author":"Li","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"112542","DOI":"10.1016\/j.celrep.2023.112542","article-title":"A Wnt-induced lncRNA-DGCR5 splicing switch drives tumor-promoting inflammation in esophageal squamous cell carcinoma","volume":"42","author":"Li","year":"","journal-title":"Cell Rep."},{"key":"B67","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41568-022-00537-3","article-title":"STAT proteins in cancer: orchestration of metabolism","volume":"23","author":"Li","year":"","journal-title":"Nat. Rev. Cancer"},{"key":"B68","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.7150\/thno.52570","article-title":"Engineering exosomes for targeted drug delivery","volume":"11","author":"Liang","year":"2021","journal-title":"Theranostics"},{"key":"B69","doi-asserted-by":"publisher","first-page":"e162951","DOI":"10.1172\/jci162951","article-title":"Long noncoding RNA HITT coordinates with RGS2 to inhibit PD-L1 translation in T cell immunity","volume":"133","author":"Lin","year":"2023","journal-title":"J. Clin. Invest."},{"key":"B70","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.ymthe.2021.08.011","article-title":"lncRNA ITGB8-AS1 functions as a ceRNA to promote colorectal cancer growth and migration through integrin-mediated focal adhesion signaling","volume":"30","author":"Lin","year":"2022","journal-title":"Mol. Ther."},{"key":"B71","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/cac2.12507","article-title":"LncRNA-CCAT5-mediated crosstalk between Wnt\/\u03b2-Catenin and STAT3 signaling suggests novel therapeutic approaches for metastatic gastric cancer with high Wnt activity","volume":"44","author":"Liu","year":"2024","journal-title":"Cancer Commun. (Lond)"},{"key":"B72","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.canlet.2021.12.026","article-title":"SP1-induced lncRNA DUBR promotes stemness and oxaliplatin resistance of hepatocellular carcinoma via E2F1-CIP2A feedback","volume":"528","author":"Liu","year":"","journal-title":"Cancer Lett."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.jid.2019.09.025","article-title":"E2F1\/IGF-1R loop contributes to BRAF inhibitor resistance in melanoma","volume":"140","author":"Liu","year":"2020","journal-title":"J. Invest. Dermatol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"4071","DOI":"10.7150\/ijbs.69495","article-title":"A positive feedback loop of CENPU\/E2F6\/E2F1 facilitates proliferation and metastasis via ubiquitination of E2F6 in hepatocellular carcinoma","volume":"18","author":"Liu","year":"","journal-title":"Int. J. Biol. Sci."},{"key":"B75","doi-asserted-by":"publisher","first-page":"9620","DOI":"10.7150\/thno.44176","article-title":"LncRNA-SLC16A1-AS1 induces metabolic reprogramming during Bladder Cancer progression as target and co-activator of E2F1","volume":"10","author":"Logotheti","year":"2020","journal-title":"Theranostics"},{"key":"B76","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41571-023-00844-0","article-title":"Lung cancer in patients who have never smoked - an emerging disease","volume":"21","author":"LoPiccolo","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s13046-018-0945-6","article-title":"Long noncoding RNA LINC00511 contributes to breast cancer tumourigenesis and stemness by inducing the miR-185-3p\/E2F1\/Nanog axis","volume":"37","author":"Lu","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B78","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1158\/1541-7786.Mcr-16-0331","article-title":"LncRNA GAS5 inhibits cellular proliferation by targeting P27(kip1)","volume":"15","author":"Luo","year":"2017","journal-title":"Mol. Cancer Res."},{"key":"B79","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.omtn.2021.04.022","article-title":"lncRNA GAS6-AS1 inhibits progression and glucose metabolism reprogramming in LUAD via repressing E2F1-mediated transcription of GLUT1","volume":"25","author":"Luo","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"B80","doi-asserted-by":"publisher","first-page":"6010","DOI":"10.18632\/aging.202522","article-title":"Exosomal long non-coding RNA LINC00662 promotes non-small cell lung cancer progression by miR-320d\/E2F1 axis","volume":"13","author":"Lv","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"B81","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.actbio.2022.11.016","article-title":"A miRNA-based gene therapy nanodrug synergistically enhances pro-inflammatory antitumor immunity against melanoma","volume":"155","author":"Ma","year":"2023","journal-title":"Acta Biomater."},{"key":"B82","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1080\/15384101.2020.1801190","article-title":"The E2F1 transcription factor and RB tumor suppressor moonlight as DNA repair factors","volume":"19","author":"Manickavinayaham","year":"2020","journal-title":"Cell Cycle"},{"key":"B83","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/j.1442-2050.2005.00463.x","article-title":"Cyclin D1, E2F1 expression levels are associated with characteristics and prognosis of esophageal squamous cell carcinoma","volume":"18","author":"Mega","year":"2005","journal-title":"Dis. Esophagus"},{"key":"B84","doi-asserted-by":"publisher","first-page":"122322","DOI":"10.1016\/j.lfs.2023.122322","article-title":"Molecular mechanism of lncRNAs in pathogenesis and diagnosis of auto-immune diseases, with a special focus on lncRNA-based therapeutic approaches","volume":"336","author":"Mehmandar-Oskuie","year":"2024","journal-title":"Life Sci."},{"key":"B85","doi-asserted-by":"publisher","first-page":"e1360","DOI":"10.1038\/cddis.2014.326","article-title":"Transcription addiction: can we garner the Yin and Yang functions of E2F1 for cancer therapy?","volume":"5","author":"Meng","year":"2014","journal-title":"Cell Death Dis."},{"key":"B86","doi-asserted-by":"publisher","first-page":"e1223","DOI":"10.1002\/iid3.1223","article-title":"LncRNA MIR100HG affects the proliferation and metastasis of lung cancer cells through mediating the microRNA-5590-3p\/DCBLD2 axis","volume":"12","author":"Min","year":"2024","journal-title":"Immun. Inflamm. Dis."},{"key":"B87","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/jb\/mvab042","article-title":"Long non-coding RNA ZEB1-AS1 promotes proliferation and metastasis of hepatocellular carcinoma cells by targeting miR-299-3p\/E2F1 axis","volume":"170","author":"Mu","year":"2021","journal-title":"J. Biochem."},{"key":"B88","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/jso.27548","article-title":"Cancer surgery on the global stage: updates and progress","volume":"129","author":"Murthy","year":"2024","journal-title":"J. Surg. Oncol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"437","DOI":"10.4103\/0301-4738.36478","article-title":"A comparative debate on the various anti-vascular endothelial growth factor drugs: pegaptanib sodium (Macugen), ranibizumab (Lucentis) and bevacizumab (Avastin)","volume":"55","author":"Nagpal","year":"2007","journal-title":"Indian J. Ophthalmol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41576-023-00662-1","article-title":"Non-coding RNAs in disease: from mechanisms to therapeutics","volume":"25","author":"Nemeth","year":"2024","journal-title":"Nat. Rev. Genet."},{"key":"B91","doi-asserted-by":"publisher","first-page":"9949","DOI":"10.26355\/eurrev_202010_23207","article-title":"E2F1-induced upregulation of lncRNA HCG18 stimulates proliferation and migration in gastric cancer by binding to miR-197-3p","volume":"24","author":"Niu","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B92","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1038\/s41598-017-02357-0","article-title":"The long non-coding RNA LINC00152 is essential for cell cycle progression through mitosis in HeLa cells","volume":"7","author":"N\u00f6tzold","year":"2017","journal-title":"Sci. Rep."},{"key":"B93","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.semcancer.2019.08.007","article-title":"SOX2 in development and cancer biology","volume":"67","author":"Novak","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ebiom.2016.10.026","article-title":"H19 noncoding RNA, an independent prognostic factor, regulates essential Rb-E2F and CDK8-\u03b2-catenin signaling in colorectal cancer","volume":"13","author":"Ohtsuka","year":"2016","journal-title":"EBioMedicine"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1159\/000487460","article-title":"The LncRNA EPEL promotes lung cancer cell proliferation through E2F target activation","volume":"45","author":"Park","year":"2018","journal-title":"Cell Physiol. Biochem."},{"key":"B96","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/hco.0000000000000724","article-title":"RNA-based therapeutics in cardiovascular disease","volume":"35","author":"Pham","year":"2020","journal-title":"Curr. Opin. Cardiol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1038\/s41598-022-06154-2","article-title":"E2F1-induced lncRNA, EMSLR regulates lncRNA LncPRESS1","volume":"12","author":"Priyanka","year":"2022","journal-title":"Sci. Rep."},{"key":"B98","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.2147\/cmar.S171652","article-title":"E2F1 induces LSINCT5 transcriptional activity and promotes gastric cancer progression by affecting the epithelial-mesenchymal transition","volume":"10","author":"Qi","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"B99","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.jconrel.2022.10.050","article-title":"Nano drug delivery systems for antisense oligonucleotides (ASO) therapeutics","volume":"352","author":"Ramasamy","year":"2022","journal-title":"J. Control Release"},{"key":"B100","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1126\/science.aay5967","article-title":"An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors","volume":"367","author":"Reinhard","year":"2020","journal-title":"Science"},{"key":"B101","doi-asserted-by":"publisher","first-page":"4164","DOI":"10.1038\/onc.2013.470","article-title":"E2F1 drives chemotherapeutic drug resistance via ABCG2","volume":"33","author":"Rosenfeldt","year":"2014","journal-title":"Oncogene"},{"key":"B102","doi-asserted-by":"publisher","first-page":"122544","DOI":"10.1016\/j.lfs.2024.122544","article-title":"Multifaced roles of the long non-coding RNA DRAIC in cancer progression","volume":"343","author":"Sakurai","year":"2024","journal-title":"Life Sci."},{"key":"B103","doi-asserted-by":"publisher","first-page":"131075","DOI":"10.1016\/j.ijbiomac.2024.131075","article-title":"Regulatory and therapeutic implications of competing endogenous RNA network in breast cancer progression and metastasis: a review","volume":"266","author":"Saranya","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.omtn.2023.05.020","article-title":"A protein domain-oriented approach to expand the opportunities of therapeutic exon skipping for USH2A-associated retinitis pigmentosa","volume":"32","author":"Schellens","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"B105","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1007\/s00018-016-2174-5","article-title":"Mechanisms of long noncoding RNA function in development and disease","volume":"73","author":"Schmitz","year":"2016","journal-title":"Cell Mol. Life Sci."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1101\/gr.208652.116","article-title":"The identification and functional annotation of RNA structures conserved in vertebrates","volume":"27","author":"Seemann","year":"2017","journal-title":"Genome Res."},{"key":"B107","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.semcancer.2022.05.013","article-title":"Long non-coding RNA and RNA-binding protein interactions in cancer: experimental and machine learning approaches","volume":"86","author":"Shaath","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"33249","DOI":"10.18632\/oncotarget.26064","article-title":"Modeling and antitumor studies of a modified L-penetratin peptide targeting E2F in lung cancer and prostate cancer","volume":"9","author":"Shaik","year":"2018","journal-title":"Oncotarget"},{"key":"B109","doi-asserted-by":"publisher","first-page":"795","DOI":"10.18388\/abp.2020_6118","article-title":"E2F1-induced long non-coding RNA MCF2L-AS1 modulates Cyclin D1 mRNA stability through ELAVL1 to induce Gefitinib resistance in non-small cell lung cancer","volume":"69","author":"Shan","year":"2022","journal-title":"Acta Biochim. Pol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/s41417-023-00607-0","article-title":"E2F1-mediated KDM4A-AS1 up-regulation promotes EMT of hepatocellular carcinoma cells by recruiting ILF3 to stabilize AURKA mRNA","volume":"30","author":"Shen","year":"2023","journal-title":"Cancer Gene Ther."},{"key":"B111","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/s41587-019-0106-2","article-title":"Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index","volume":"37","author":"Shen","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3892\/ijo.2021.5231","article-title":"lncRNA NEAT1 facilitates the progression of colorectal cancer via the KDM5A\/Cul4A and Wnt signaling pathway","volume":"59","author":"Shen","year":"2021","journal-title":"Int. J. Oncol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41576-020-0210-7","article-title":"Pan-genomics in the human genome era","volume":"21","author":"Sherman","year":"2020","journal-title":"Nat. Rev. Genet."},{"key":"B114","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1002\/jcp.29194","article-title":"LncRNA SNHG3 is activated by E2F1 and promotes proliferation and migration of non-small-cell lung cancer cells through activating TGF-\u03b2 pathway and IL-6\/JAK2\/STAT3 pathway","volume":"235","author":"Shi","year":"2020","journal-title":"J. Cell Physiol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1002\/mc.22120","article-title":"A critical role for the long non-coding RNA GAS5 in proliferation and apoptosis in non-small-cell lung cancer","volume":"54","author":"Shi","year":"2015","journal-title":"Mol. Carcinog."},{"key":"B116","doi-asserted-by":"publisher","first-page":"155282","DOI":"10.1016\/j.prp.2024.155282","article-title":"Targeting notch-related lncRNAs in cancer: insights into molecular regulation and therapeutic potential","volume":"257","author":"Siddique","year":"2024","journal-title":"Pathol. Res. Pract."},{"key":"B117","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/s0140-6736(20)31288-5","article-title":"Gastric cancer","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet"},{"key":"B118","doi-asserted-by":"publisher","first-page":"e220","DOI":"10.1002\/ctm2.220","article-title":"Long noncoding RNA CASC11 promotes hepatocarcinogenesis and HCC progression through EIF4A3-mediated E2F1 activation","volume":"10","author":"Song","year":"2020","journal-title":"Clin. Transl. Med."},{"key":"B119","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/s41419-022-05414-3","article-title":"E2F1-initiated transcription of PRSS22 promotes breast cancer metastasis by cleaving ANXA1 and activating FPR2\/ERK signaling pathway","volume":"13","author":"Song","year":"2022","journal-title":"Cell Death Dis."},{"key":"B120","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12964-024-01599-6","article-title":"Super enhancer lncRNAs: a novel hallmark in cancer","volume":"22","author":"Song","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"B121","doi-asserted-by":"publisher","first-page":"e114760","DOI":"10.15252\/embj.2023114760","article-title":"RNA-based medicine: from molecular mechanisms to therapy","volume":"42","author":"Sparmann","year":"2023","journal-title":"Embo J."},{"key":"B122","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1159\/000098504","article-title":"Vascular endothelial growth factor and the potential therapeutic use of pegaptanib (macugen) in diabetic retinopathy","volume":"39","author":"Starita","year":"2007","journal-title":"Dev. Ophthalmol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.1158\/0008-5472.Can-23-0544","article-title":"Super enhancer-regulated LncRNA LINC01089 induces alternative splicing of DIAPH3 to drive hepatocellular carcinoma metastasis","volume":"83","author":"Su","year":"2023","journal-title":"Cancer Res."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1140460","DOI":"10.3389\/fonc.2023.1140460","article-title":"Identification of lncRNA and mRNA regulatory networks associated with gastric cancer progression","volume":"13","author":"Sun","year":"2023","journal-title":"Front. Oncol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/1471-2407-14-319","article-title":"Decreased expression of long noncoding RNA GAS5 indicates a poor prognosis and promotes cell proliferation in gastric cancer","volume":"14","author":"Sun","year":"2014","journal-title":"BMC Cancer"},{"key":"B126","doi-asserted-by":"publisher","first-page":"6299","DOI":"10.1158\/0008-5472.Can-16-0356","article-title":"LncRNA HOXA11-AS promotes proliferation and invasion of gastric cancer by scaffolding the chromatin modification factors PRC2, LSD1, and DNMT1","volume":"76","author":"Sun","year":"2016","journal-title":"Cancer Res."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.4251\/wjgo.v15.i11.1974","article-title":"Long non-coding RNA CDKN2B-AS1 promotes hepatocellular carcinoma progression via E2F transcription factor 1\/G protein subunit alpha Z axis","volume":"15","author":"Tao","year":"2023","journal-title":"World J. Gastrointest. Oncol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"122613","DOI":"10.1016\/j.lfs.2024.122613","article-title":"Exploring ncRNA-mediated regulation of EGFR signalling in glioblastoma: from mechanisms to therapeutics","volume":"345","author":"Thapa","year":"2024","journal-title":"Life Sci."},{"key":"B129","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1158\/1055-9965.Epi-15-0578","article-title":"Global cancer incidence and mortality rates and trends--an update","volume":"25","author":"Torre","year":"2016","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"B130","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1124\/jpet.122.001234","article-title":"RNAi-based therapeutics and novel RNA bioengineering technologies","volume":"384","author":"Traber","year":"2023","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B131","doi-asserted-by":"publisher","first-page":"718466","DOI":"10.3389\/fcell.2021.718466","article-title":"The off-targets of clustered regularly interspaced short palindromic repeats gene editing","volume":"9","author":"Vicente","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/s0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"key":"B133","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1089\/dna.2020.5426","article-title":"E2F1-Induced overexpression of long noncoding RNA SBF2-AS1 promotes non-small-cell lung cancer metastasis through regulating miR-362-3p\/GRB2 Axis","volume":"39","author":"Wang","year":"2020","journal-title":"DNA Cell Biol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12885-023-10707-7","article-title":"TUBA1C: a new potential target of LncRNA EGFR-AS1 promotes gastric cancer progression","volume":"23","author":"Wang","year":"","journal-title":"BMC Cancer"},{"key":"B135","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.7150\/ijbs.81738","article-title":"LncRNA PTTG3P promotes tumorigenesis and metastasis of NSCLC by binding with ILF3 to maintain mRNA stability and form a positive feedback loop with E2F1","volume":"19","author":"Wang","year":"","journal-title":"Int. J. Biol. Sci."},{"key":"B136","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1002\/ctm2.46","article-title":"Regulatory roles of HSPA6 in Actinidia chinensis Planch. root extract (acRoots)-inhibited lung cancer proliferation","volume":"10","author":"Wang","year":"2020","journal-title":"Clin. Transl. Med."},{"key":"B137","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.eururo.2017.04.005","article-title":"Preclinical study using Malat1 small interfering RNA or androgen receptor splicing variant 7 degradation enhancer ASC-J9(\u00ae) to suppress enzalutamide-resistant prostate cancer progression","volume":"72","author":"Wang","year":"","journal-title":"Eur. Urol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1007\/s12094-023-03165-x","article-title":"LncRNA CASC19: a novel oncogene involved in human cancer","volume":"25","author":"Wang","year":"","journal-title":"Clin. Transl. Oncol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1186\/s12885-017-3701-y","article-title":"Transcription factor E2F1 promotes EMT by regulating ZEB2 in small cell lung cancer","volume":"17","author":"Wang","year":"","journal-title":"BMC Cancer"},{"key":"B140","doi-asserted-by":"publisher","first-page":"e18022","DOI":"10.1111\/jcmm.18022","article-title":"PIN1P1 is activated by CREB1 and promotes gastric cancer progression via interacting with YBX1 and upregulating PIN1","volume":"28","author":"Wang","year":"2024","journal-title":"J. Cell Mol. Med."},{"key":"B141","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2478\/acph-2024-0009","article-title":"Long non-coding RNA TINCR suppresses growth and epithelial-mesenchymal transition by inhibiting Wnt\/\u03b2-catenin signaling pathway in human pancreatic cancer PANC-1 cells: insights from in vitro and in vivo studies","volume":"74","author":"Wei","year":"2024","journal-title":"Acta Pharm."},{"key":"B142","doi-asserted-by":"publisher","first-page":"103553","DOI":"10.1016\/j.jddst.2022.103553","article-title":"Lipid nanoparticles in the development of mRNA vaccines for COVID-19","volume":"74","author":"Wilson","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41573-021-00219-z","article-title":"Noncoding RNA therapeutics - challenges and potential solutions","volume":"20","author":"Winkle","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"B144","doi-asserted-by":"publisher","first-page":"7890","DOI":"10.18632\/aging.204315","article-title":"Comprehensive bioinformatics analysis of ribonucleoside diphosphate reductase subunit M2(RRM2) gene correlates with prognosis and tumor immunotherapy in pan-cancer","volume":"14","author":"Wu","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"B145","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12943-020-1147-3","article-title":"Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA","volume":"19","author":"Wu","year":"2020","journal-title":"Mol. Cancer"},{"key":"B146","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12943-018-0777-1","article-title":"Management of acquired resistance to EGFR TKI-targeted therapy in advanced non-small cell lung cancer","volume":"17","author":"Wu","year":"2018","journal-title":"Mol. Cancer"},{"key":"B147","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s11658-024-00560-2","article-title":"Role of ferroptosis and ferroptosis-related long non\u2019coding RNA in breast cancer","volume":"29","author":"Xiang","year":"2024","journal-title":"Cell Mol. Biol. Lett."},{"key":"B148","doi-asserted-by":"publisher","first-page":"101304","DOI":"10.1016\/j.tranon.2021.101304","article-title":"LncRNA DLGAP1-AS2 promotes the radioresistance of rectal cancer stem cells by upregulating CD151 expression via E2F1","volume":"18","author":"Xiao","year":"2022","journal-title":"Transl. Oncol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1073\/pnas.1420294112","article-title":"Boosting CRISPR\/Cas9 multiplex editing capability with the endogenous tRNA-processing system","volume":"112","author":"Xie","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B150","doi-asserted-by":"publisher","first-page":"901","DOI":"10.18632\/oncotarget.1809","article-title":"A novel peptide that inhibits E2F transcription and regresses prostate tumor xenografts","volume":"5","author":"Xie","year":"2014","journal-title":"Oncotarget"},{"key":"B151","doi-asserted-by":"publisher","first-page":"742","DOI":"10.4161\/cbt.25184","article-title":"Antitumor and modeling studies of a penetratin-peptide that targets E2F-1 in small cell lung cancer","volume":"14","author":"Xie","year":"2013","journal-title":"Cancer Biol. Ther."},{"key":"B152","doi-asserted-by":"publisher","first-page":"530933","DOI":"10.3389\/fonc.2020.530933","article-title":"E2F1 induces KIF26A transcription and promotes cell cycle progression via CDK-RB-E2Fs feedback loop in breast cancer","volume":"10","author":"Xu","year":"","journal-title":"Front. Oncol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.tem.2023.02.007","article-title":"ncRNA-mediated fatty acid metabolism reprogramming in HCC","volume":"34","author":"Xu","year":"2023","journal-title":"Trends Endocrinol. Metab."},{"key":"B154","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12943-020-01276-5","article-title":"Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities","volume":"19","author":"Xu","year":"","journal-title":"Mol. Cancer"},{"key":"B155","doi-asserted-by":"publisher","first-page":"e23594","DOI":"10.1002\/jbt.23594","article-title":"LncRNA LINC01703 promotes the proliferation, migration, and invasion of colorectal cancer by activating PI3K\/AKT pathway","volume":"38","author":"Xu","year":"2024","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1093\/carcin\/bgad053","article-title":"MALAT1 regulates network of microRNA-15a\/16-VEGFA to promote tumorigenesis and angiogenesis in multiple myeloma","volume":"44","author":"Yan","year":"","journal-title":"Carcinogenesis"},{"key":"B157","doi-asserted-by":"publisher","first-page":"103432","DOI":"10.1016\/j.drudis.2022.103432","article-title":"Recent advances in predicting lncRNA-disease associations based on computational methods","volume":"28","author":"Yan","year":"","journal-title":"Drug Discov. Today"},{"key":"B158","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3892\/mmr.2024.13217","article-title":"Long non-coding RNA DANCR aggravates breast cancer through the miR-34c\/E2F1 feedback loop","volume":"29","author":"Yan","year":"2024","journal-title":"Mol. Med. Rep."},{"key":"B159","doi-asserted-by":"publisher","first-page":"114698","DOI":"10.1016\/j.biopha.2023.114698","article-title":"ncRNA-mediated ceRNA regulatory network: transcriptomic insights into breast cancer progression and treatment strategies","volume":"162","author":"Yang","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"B160","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/cac2.12254","article-title":"New insights into the interplay between long non-coding RNAs and RNA-binding proteins in cancer","volume":"42","author":"Yao","year":"2022","journal-title":"Cancer Commun. (Lond)"},{"key":"B161","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12943-021-01489-2","article-title":"Combination strategies with PD-1\/PD-L1 blockade: current advances and future directions","volume":"21","author":"Yi","year":"2022","journal-title":"Mol. Cancer"},{"key":"B162","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","article-title":"Targeting NF-\u03baB pathway for the therapy of diseases: mechanism and clinical study","volume":"5","author":"Yu","year":"","journal-title":"Signal Transduct. Target Ther."},{"key":"B163","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.3390\/biom10121646","article-title":"Long noncoding RNA DANCR activates wnt\/\u03b2-catenin signaling through MiR-216a inhibition in non-small cell lung cancer","volume":"10","author":"Yu","year":"","journal-title":"Biomolecules"},{"key":"B164","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/cgt.2017.10","article-title":"lncRNA-HIT promotes cell proliferation of non-small cell lung cancer by association with E2F1","volume":"24","author":"Yu","year":"2017","journal-title":"Cancer Gene Ther."},{"key":"B165","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1158\/0008-5472.Can-23-0015","article-title":"LncRNA AGPG confers endocrine resistance in breast cancer by promoting E2F1 activity","volume":"83","author":"Yu","year":"2023","journal-title":"Cancer Res."},{"key":"B166","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/onc.2016.304","article-title":"Wnt signaling in cancer","volume":"36","author":"Zhan","year":"2017","journal-title":"Oncogene"},{"key":"B167","doi-asserted-by":"publisher","first-page":"111837","DOI":"10.1016\/j.mrfmmm.2023.111837","article-title":"The E2F1\/MELTF axis fosters the progression of lung adenocarcinoma by regulating the Notch signaling pathway","volume":"827","author":"Zhang","year":"2023","journal-title":"Mutat. Res."},{"key":"B168","doi-asserted-by":"publisher","first-page":"121434","DOI":"10.1016\/j.lfs.2023.121434","article-title":"Shiny transcriptional junk: lncRNA-derived peptides in cancers and immune responses","volume":"316","author":"Zhang","year":"2023","journal-title":"Life Sci."},{"key":"B169","doi-asserted-by":"publisher","first-page":"643163","DOI":"10.3389\/fonc.2021.643163","article-title":"The long non-coding RNA TMPO-AS1 promotes bladder cancer growth and progression via OTUB1-induced E2F1 deubiquitination","volume":"11","author":"Zhang","year":"2021","journal-title":"Front. Oncol."},{"key":"B170","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.bbrc.2020.07.044","article-title":"E2F1-induced ferritin heavy chain 1 pseudogene 3 (FTH1P3) accelerates non-small cell lung cancer gefitinib resistance","volume":"530","author":"Zheng","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B171","doi-asserted-by":"publisher","first-page":"4911","DOI":"10.1080\/21655979.2022.2037226","article-title":"Actinidia chinensis Planch Root extract suppresses the growth and metastasis of hypopharyngeal carcinoma by inhibiting E2F Transcription Factor 1-mediated MNX1 antisense RNA 1","volume":"13","author":"Zheng","year":"2022","journal-title":"Bioengineered"},{"key":"B172","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12943-024-01992-2","article-title":"tRNA-derived small RNAs in human cancers: roles, mechanisms, and clinical application","volume":"23","author":"Zhou","year":"2024","journal-title":"Mol. Cancer"},{"key":"B173","doi-asserted-by":"publisher","first-page":"4340","DOI":"10.1158\/0008-5472.Can-22-1289","article-title":"MNX1-AS1 promotes phase separation of IGF2BP1 to drive c-myc-mediated cell-cycle progression and proliferation in lung cancer","volume":"82","author":"Zhu","year":"2022","journal-title":"Cancer Res."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1432490\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T05:05:12Z","timestamp":1721883912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1432490\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,25]]},"references-count":173,"alternative-id":["10.3389\/fphar.2024.1432490"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1432490","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,25]]},"article-number":"1432490"}}